Have a personal or library account? Click to login
Utility of chloroquine diphosphate in the blood bank laboratory Cover

Utility of chloroquine diphosphate in the blood bank laboratory

By: T. Aye and  P.A. Arndt  
Paid access
|Oct 2019

Abstract

Chloroquine diphosphate (CDP) is a helpful tool in the blood bank for two main applications. The most common application is to render direct antiglobulin test–positive red blood cells (RBCs) free from membrane-bound IgG; these treated RBCs can then be used for autologous adsorption and/or to determine the patient’s RBC phenotype. Another common use of CDP is to remove human leukocyte antigens (HLAs) from RBCs to help identify or exclude the presence of antibodies to HLAs expressed on RBCs, for example, Bennett-Goodspeed (Bg) antigens. In this review, the principles, applications, and limitations of using CDP are discussed. Immunohematology 2018;34:98–102.

DOI: https://doi.org/10.21307/immunohematology-2018-016 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 98 - 102
Published on: Oct 16, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 T. Aye, P.A. Arndt, published by American National Red Cross
This work is licensed under the Creative Commons License.